X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6067) 6067
Publication (321) 321
Newsletter (127) 127
Book Review (79) 79
Book Chapter (5) 5
Conference Proceeding (4) 4
Newspaper Article (3) 3
Dissertation (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4627) 4627
oncology (3005) 3005
female (2887) 2887
male (2658) 2658
fluorouracil (2508) 2508
fluorouracil - administration & dosage (2341) 2341
middle aged (2297) 2297
aged (2117) 2117
index medicus (2113) 2113
5-fluorouracil (2065) 2065
chemotherapy (1937) 1937
adult (1798) 1798
cancer (1634) 1634
antineoplastic combined chemotherapy protocols - therapeutic use (1595) 1595
fluorouracil - pharmacokinetics (1476) 1476
pharmacology & pharmacy (1456) 1456
animals (1455) 1455
colorectal neoplasms - drug therapy (1124) 1124
fluorouracil - therapeutic use (1028) 1028
colorectal cancer (1021) 1021
treatment outcome (984) 984
pharmacokinetics (949) 949
capecitabine (877) 877
antineoplastic combined chemotherapy protocols - adverse effects (843) 843
fluorouracil - adverse effects (838) 838
leucovorin (792) 792
deoxycytidine - analogs & derivatives (790) 790
fluorouracil - analogs & derivatives (769) 769
medicine & public health (697) 697
mice (666) 666
drug administration schedule (652) 652
care and treatment (645) 645
leucovorin - administration & dosage (643) 643
fluorouracil - pharmacology (639) 639
camptothecin - analogs & derivatives (636) 636
antineoplastic combined chemotherapy protocols - administration & dosage (626) 626
colorectal neoplasms - pathology (624) 624
oxaliplatin (603) 603
research (598) 598
antimetabolites, antineoplastic - administration & dosage (597) 597
antimetabolites, antineoplastic - pharmacokinetics (582) 582
dose-response relationship, drug (578) 578
irinotecan (558) 558
therapy (543) 543
aged, 80 and over (540) 540
neoplasms - drug therapy (516) 516
antimetabolites, antineoplastic - therapeutic use (511) 511
toxicity (505) 505
administration, oral (503) 503
deoxycytidine - administration & dosage (498) 498
carcinoma (493) 493
metastasis (491) 491
rats (490) 490
camptothecin - administration & dosage (462) 462
analysis (456) 456
antineoplastic agents - therapeutic use (455) 455
breast neoplasms - drug therapy (447) 447
trial (445) 445
pharmacology/toxicology (434) 434
antineoplastic agents - administration & dosage (432) 432
infusions, intravenous (432) 432
drug therapy (431) 431
adenocarcinoma - drug therapy (428) 428
cisplatin (415) 415
neoplasm metastasis (412) 412
organoplatinum compounds - administration & dosage (405) 405
fluorouracil - blood (398) 398
1st-line treatment (381) 381
metastatic colorectal-cancer (380) 380
disease-free survival (373) 373
cancer research (371) 371
combination (371) 371
fluorouracil - metabolism (365) 365
cell line, tumor (354) 354
stomach neoplasms - drug therapy (351) 351
tegafur - administration & dosage (350) 350
tumors (349) 349
antineoplastic combined chemotherapy protocols - pharmacokinetics (348) 348
colorectal-cancer (347) 347
cisplatin - administration & dosage (346) 346
liver neoplasms - secondary (345) 345
health aspects (339) 339
liver neoplasms - drug therapy (333) 333
survival rate (329) 329
antineoplastic agents - pharmacokinetics (328) 328
colonic neoplasms - drug therapy (328) 328
antimetabolites, antineoplastic - adverse effects (327) 327
survival analysis (321) 321
randomized-trial (320) 320
dihydropyrimidine dehydrogenase (318) 318
breast cancer (317) 317
antineoplastic agents (316) 316
prognosis (316) 316
phase-ii (315) 315
surgery (309) 309
drug combinations (306) 306
combined modality therapy (303) 303
bevacizumab (300) 300
drugs (298) 298
survival (297) 297
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5871) 5871
Japanese (206) 206
French (49) 49
Chinese (35) 35
German (27) 27
Russian (9) 9
Spanish (3) 3
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 06/2000, Volume 59, Issue 6, pp. 1261 - 1277
Neuroblastoma represents one of the most challenging malignancies for treatment decisions because of its unusual biological behaviour. The features include... 
Melphalan, pharmacokinetics | Topoisomerase inhibitors, therapeutic use | Cytarabine, pharmacokinetics | Teniposide, therapeutic use | Fluorouracil, pharmacokinetics | Research and development | Thioguanine, pharmacokinetics | Hydroxycarbamide, pharmacokinetics | Etoposide, pharmacokinetics | Vincristine, pharmacokinetics | Thiotepa, pharmacokinetics | Cisplatin, pharmacokinetics | Doxorubicin, pharmacokinetics | Zilascorb, pharmacokinetics | Procarbazine, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Antineoplastics, therapeutic use | Bleomycin, pharmacokinetics | Busulfan, pharmacokinetics | Dacarbazine, therapeutic use | Ifosfamide, pharmacokinetics | Vinblastine, therapeutic use | Dactinomycin, pharmacokinetics | Lomustine, pharmacokinetics | Mercaptopurine, pharmacokinetics | Carboplatin, pharmacokinetics | Mitoxantrone, pharmacokinetics | Neuroblastoma, treatment | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | NEURO-BLASTOMA | BONE-MARROW TRANSPLANTATION | MESSENGER-RNA | CHROMOSOME 1P | PEDIATRIC-ONCOLOGY-GROUP | METASTATIC NEUROBLASTOMA | CHILDHOOD NEUROBLASTOMA | CLINICAL RELEVANCE | GENE AMPLIFICATION | PHARMACOLOGY & PHARMACY | TOXICOLOGY | MULTIDRUG-RESISTANCE | Prognosis | Humans | Neuroblastoma - drug therapy | Hematopoietic Stem Cell Transplantation | Drug Resistance, Neoplasm | Transplantation, Autologous | Neuroblastoma - mortality
Journal Article
Anti-Cancer Agents in Medicinal Chemistry, ISSN 1871-5206, 2013, Volume 13, Issue 8, pp. 1197 - 1203
Journal Article
Molecules, ISSN 1420-3049, 09/2017, Volume 22, Issue 9, p. 1488
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2014, Volume 73, Issue 4, pp. 737 - 747
The aim of this study was to characterize trastuzumab population pharmacokinetics (PKs) in patients with human epidermal growth factor receptor 2-positive... 
Population pharmacokinetics | Gastroesophageal junction cancer | Medicine & Public Health | Exposure–response | Oncology | Cancer Research | Pharmacology/Toxicology | Gastric cancer | Trastuzumab | Exposure-response | SURVIVAL | EGF | RECEPTOR | HER-2 | AMPLIFICATION | GENE | ONCOLOGY | PHARMACOLOGY & PHARMACY | rastuzumab | Receptor, ErbB-2 - genetics | Capecitabine | Esophageal Neoplasms - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Receptor, ErbB-2 - metabolism | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Antibodies, Monoclonal, Humanized - blood | Esophageal Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Esophagogastric Junction - metabolism | Esophagogastric Junction - pathology | Stomach Neoplasms - drug therapy | Stomach Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Epidermal growth factor | Analysis | Antineoplastic agents | Cancer
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2008, Volume 62, Issue 5, pp. 779 - 786
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2002, Volume 94, Issue 24, pp. 1883 - 1888
The prescribed dose of anticancer agents is most commonly calculated using body surface area as the only independent variable, and it has been shown that this... 
TOPOISOMERASE-I INHIBITOR | INTRAVENOUS CISPLATIN | DOSE-ESCALATION | ADVANCED SOLID TUMORS | ONCOLOGY | ORAL TOPOTECAN | MATRIX-METALLOPROTEINASE INHIBITOR | SCHEDULE | CLINICAL PHARMACOKINETICS | PHASE-I | CREMOPHOR EL | Cytosine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Drugs, Investigational - pharmacokinetics | Cytosine - administration & dosage | Male | Paclitaxel - pharmacokinetics | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Fluorouracil - administration & dosage | Uracil - administration & dosage | Dacarbazine - analogs & derivatives | Adult | Dacarbazine - pharmacokinetics | Dioxolanes - pharmacokinetics | Female | Antineoplastic Agents - pharmacokinetics | Retrospective Studies | Body Surface Area | Paclitaxel - administration & dosage | Dacarbazine - administration & dosage | Cytosine - pharmacokinetics | Drug Administration Schedule | Docosahexaenoic Acids - administration & dosage | Docosahexaenoic Acids - pharmacokinetics | Drugs, Investigational - administration & dosage | Dioxolanes - administration & dosage | Infusions, Intravenous | Temozolomide | Fluorouracil - pharmacokinetics | Uracil - pharmacokinetics | Clinical Trials, Phase I as Topic | Uracil - analogs & derivatives | Antimitotic agents | Drug metabolism | Dosage and administration | Testolactone | Antineoplastic agents | Analysis
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 05/2015, Volume 32, Issue 5, pp. 1585 - 1603
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 01/2017, Volume 24, Issue 2, pp. 193 - 214
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2013, Volume 24, Issue 6, pp. 1560 - 1567
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 06/2014, Volume 73, Issue 6, pp. 1285 - 93
PURPOSE: The aims of the present study were (1) to investigate the impact of great age on pharmacokinetics of capecitabine and its metabolites and (2) to... 
Age Factors | Humans | Antineoplastic Combined Chemotherapy Protocols | Male | Breast Neoplasms | Life Sciences | Deoxycytidine | Aged, 80 and over | Antimetabolites, Antineoplastic | Colorectal Neoplasms | Female | Aged | Pharmaceutical sciences | Fluorouracil
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 341 - 351
Journal Article